Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Teleflex Incorporated reported its second quarter 2024 earnings with several factors influencing its financial outcomes and strategic decisions.</li><li>The company experienced a slight increase in revenues, reporting $749.7 million, which marks a 0.9% rise year-over-year on a GAAP basis.</li><li>However, adjusted revenues were higher at $763.5 million, reflecting a more significant growth rate of 2.7% year-over-year, primarily driven by constant currency adjustments.</li></ul>

Teleflex Incorporated reported its second quarter 2024 earnings with several factors influencing its financial outcomes and strategic decisions.The company experienced a slight increase in revenues, reporting $749.7 million, which marks a 0.9% rise year-over-year on a GAAP basis.However, adjusted revenues were higher at $763.5 million, reflecting a more significant growth rate of 2.7% year-over-year, primarily driven by constant currency adjustments.

Teleflex Incorporated: Global Expansion with a Focus on Intra-aortic Balloon Pumps - Major Drivers

<ul><li>Teleflex Inc.'s Q1 2024 Earnings revealed promising initial results, led by Liam Kelly, the Chairman, President and Chief Executive Officer, along with Thomas Powell, the Executive Vice President, and Chief Financial Officer.</li><li>For Q1 2024, Teleflex achieved revenues of $737.8 million, a 3.8% YoY increase on a GAAP and constant currency basis.</li><li>Utilization of the company's products trend positively and was on par with expectations.</li></ul>

Teleflex Inc.'s Q1 2024 Earnings revealed promising initial results, led by Liam Kelly, the Chairman, President and Chief Executive Officer, along with Thomas Powell, the Executive Vice President, and Chief Financial Officer.For Q1 2024, Teleflex achieved revenues of $737.8 million, a 3.8% YoY increase on a GAAP and constant currency basis.Utilization of the company's products trend positively and was on par with expectations.

Teleflex Incorporated: Driving Durable Growth through Organic Growth Opportunities and Innovation! - Major Drivers

<ul><li>Teleflex Incorporated's fourth quarter 2023 earnings were decent.</li><li>Firstly, the revenues grew at 2.1% year-over-year, showing the company’s overall financial robustness.</li><li>Additionally, Teleflex saw a stable-to-improving environment for material inflation and supply chains, with continued improvements expected through 2024.</li></ul>

Teleflex Incorporated's fourth quarter 2023 earnings were decent.Firstly, the revenues grew at 2.1% year-over-year, showing the company’s overall financial robustness.Additionally, Teleflex saw a stable-to-improving environment for material inflation and supply chains, with continued improvements expected through 2024.

Teleflex Incorporated: M&A Focus & 5 Other Strategies Driving Growth! - Financial Forecasts

<ul><li>Teleflex Incorporated exceeded analyst expectations in terms of revenue and earnings, reaching $746.4 million.</li><li>The macro-environment showed stability and improvement in material inflation and supply chain dynamics on a sequential basis, aligning with the company's annual expectations.</li><li>The OEM segment demonstrated solid performance, achieving a 14% YoY revenue increase to $82.3 million.</li></ul>

Teleflex Incorporated exceeded analyst expectations in terms of revenue and earnings, reaching $746.4 million.The macro-environment showed stability and improvement in material inflation and supply chain dynamics on a sequential basis, aligning with the company's annual expectations.The OEM segment demonstrated solid performance, achieving a 14% YoY revenue increase to $82.3 million.

Teleflex Incorporated: Can The Acquisition of Palette Life Sciences Be A Game Changer? - Major Drivers

<ul><li>Teleflex managed to exceed analyst expectations in terms of revenue as well as earnings.</li><li>Adjusted earnings per share for the same period were $3.41, reflecting a 0.6% increase compared to the previous year.</li><li>The company observed a continued stabilization in hospital staffing, positively affecting second-quarter revenue growth, particularly in products tied to hospital settings.</li></ul>

Teleflex managed to exceed analyst expectations in terms of revenue as well as earnings.Adjusted earnings per share for the same period were $3.41, reflecting a 0.6% increase compared to the previous year.The company observed a continued stabilization in hospital staffing, positively affecting second-quarter revenue growth, particularly in products tied to hospital settings.

Teleflex Incorporated: Strategies Unveiled to Conquer Approvals and Surgeon Training! - Major Drivers

United States

Teleflex Incorporated is a global provider of medical technology products. The Company primarily develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Teleflex Inc (TFX US)

Teleflex Incorporated: Global Expansion with a Focus on Intra-aortic Balloon Pumps - Major Drivers

Teleflex Incorporated reported its second quarter 2024 earnings with several factors influencing its financial outcomes and strategic...

Baptista Research

Teleflex Incorporated: Driving Durable Growth through Organic Growth Opportunities and Innovation! - Major Drivers

Teleflex Inc.'s Q1 2024 Earnings revealed promising initial results, led by Liam Kelly, the Chairman, President and Chief Executive Officer, along...

Baptista Research

Teleflex Incorporated: M&A Focus & 5 Other Strategies Driving Growth! - Financial Forecasts

Teleflex Incorporated's fourth quarter 2023 earnings were decent. Firstly, the revenues grew at 2.1% year-over-year, showing the company’s overall...

Baptista Research

Teleflex Incorporated: Can The Acquisition of Palette Life Sciences Be A Game Changer? - Major Drivers

Teleflex Incorporated exceeded analyst expectations in terms of revenue and earnings, reaching $746.4 million. The macro-environment showed...

Baptista Research

Teleflex Incorporated: Strategies Unveiled to Conquer Approvals and Surgeon Training! - Major Drivers

Teleflex managed to exceed analyst expectations in terms of revenue as well as earnings. Adjusted earnings per share for the same period were...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)